01 How it works
NAD+ shuttles electrons in the reactions that make cellular energy, and it is the fuel for sirtuins and PARPs — enzymes involved in DNA repair and cellular maintenance. The idea behind supplementing is to top up levels that decline with age.
02 Common uses
03 Run profile
Started low and built up over a couple of months. Taken two or three times a week, with the days spread out, in twelve-week blocks.
The profile shows the shape. Ask for the numbers for your vial, your goal and your timeline.
04 Pairs well with
05 What to watch for
A flush — warmth, redness, a niacin-like feeling — during and just after the injection is the big one, and push speed is the main driver: going slower helps most. Nausea, headache and soreness also come up. Severe or prolonged flushing, chest tightness or persistent vomiting need attention.
06 Evidence & status
Not approved (injectable)NAD+ biology is well established; evidence that injected NAD+ improves health outcomes in people is still early.
Not FDA-approved as an injectable drug. NAD+ precursors (NMN, NR) are sold as supplements.
Sources
- NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidenceAgeing Research Reviews, 2026 · Review
- NAD+ precursor supplementation in human ageing: clinical evidence and challengesNature Metabolism, 2025 · Review
- Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future DirectionsThe Journals of Gerontology: Series A, 2023 · Review
- Amendments to the List of Bulk Drug Substances That Can Be Used to Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act (proposed rule; proposes not to include NAD)Federal Register, 2019 · Regulator document
- FDA Declares Nicotinamide Mononucleotide Is a Dietary SupplementVenable LLP (regulatory alert), 2025 · Regulator document
- Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic ActU.S. Food and Drug Administration (guidance), 2017 · Regulator document
- Bulk drug substances nominated for use in compounding under section 503A: categoriesU.S. Food and Drug Administration, 2026 · Regulator document
Status and sources last checked November 3, 2026. Something out of date? Tell us.
07 How long until it works
For injected NAD+ there is no controlled trial measuring any outcome in people, so there is no measured answer. The closest evidence is from NAD+ precursors taken by mouth (NR and NMN): in those trials blood NAD+ levels rise within one to two weeks, but the reviews that pooled the results found little consistent change in energy, physical function or other outcomes. The 2026 systematic review of NAD+ for anti-ageing and wellness found no eligible controlled trial of injected NAD+ at all.
What people report is a lift in energy and clarity in the first weeks of a block, which is why the run profile here is twelve weeks on and four off. Treat that as common use, not a finding.
08 NAD+ injections vs NMN and NR supplements
NMN and NR are precursors the body turns into NAD+; taken by mouth, they reliably raise blood NAD+ in trials, and they are the forms with the most human data. Injected NAD+ skips the conversion, which is the argument for it, but it has no outcome trials and carries the flush, nausea and site soreness that the oral forms do not.
On status: NMN was contested as a supplement ingredient in the US from 2022 until the FDA restored it in September 2025; NR has long been sold as a supplement. Injected NAD+ is not an approved drug. If the question is “which has evidence”, the precursors do; if it is “which has evidence for outcomes that matter”, as of now neither does convincingly.
The MOTS-C dossier, the other metabolic pick →09 Stacking
The common pairings are MOTS-C for metabolic support and Semax for focus. No study has tested NAD+ with either. Because NAD+ is given as a larger volume than most peptides here, people usually keep it on its own days rather than in the same syringe.
10 Where it stands legally
Injected NAD+ is not an FDA-approved drug. NAD was nominated for the 503A compounding list years ago, and FDA has placed it in Category 1 of its 503A bulk substances categories, “under evaluation”. Under FDA’s interim policy a Category 1 substance may be used in compounding while the review continues, which is how clinics supply it; the FDA has not made a final decision. It is not among the six peptides in the October 2026 HHS enforcement-discretion policy, which does not affect it either way.
NMN and NR are regulated as dietary supplements in the US.
11 FAQ
Why does it make me flush?
It is a common, niacin-type reaction, mostly driven by how fast it goes in. Slower is better.
Is it the same as NMN or NR?
Those are precursors the body converts into NAD+. Injecting NAD+ skips that step.
When will I feel it?
Some people notice energy changes within days; others feel little. It is very individual.
Is there any evidence injected NAD+ works?
Not from controlled trials: the 2026 systematic review found none for injected NAD+. The evidence that exists is for oral precursors, and it shows raised blood levels more clearly than it shows benefits.
Why not just take NMN?
Fair question. NMN and NR have the human data, no flush, and supplement status. The case for injecting rests on bypassing conversion, which has not been shown to matter for outcomes.
Can I inject NAD+ faster to get it over with?
No. Push speed is the main driver of the flush; slower is the fix, not faster.
Is NAD+ legal to compound?
FDA lists it as “under evaluation” for the 503A list, and its interim policy allows compounding from such substances meanwhile. That is a provisional position, not an approval, and it can change.
Educational information only — not medical advice. The Daily Stack does not sell or supply any products. Talk to a licensed healthcare professional about your own health decisions.